The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.
SteinCares will handle all regulatory filings, registrations and commercialization of Ranibizumab in Latin America, while Lupin will be responsible for manufacturing the same.
The homeopathic medicine is designed to relieve nighttime teething symptoms such as restlessness, irritability, painful gums and minor digestive upsets in babies.
